AstraZeneca (BUE:AZN) Other Current Liabilities : ARS1,623,574 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is AstraZeneca Other Current Liabilities?

AstraZeneca's other current liabilities for the quarter that ended in Mar. 2025 was ARS1,623,574 Mil.

AstraZeneca's quarterly other current liabilities increased from Sep. 2024 (ARS1,144,402 Mil) to Dec. 2024 (ARS17,486,130 Mil) but then declined from Dec. 2024 (ARS17,486,130 Mil) to Mar. 2025 (ARS1,623,574 Mil).

AstraZeneca's annual other current liabilities increased from Dec. 2022 (ARS2,514,582 Mil) to Dec. 2023 (ARS6,401,974 Mil) and increased from Dec. 2023 (ARS6,401,974 Mil) to Dec. 2024 (ARS17,486,130 Mil).

AstraZeneca Other Current Liabilities Historical Data

The historical data trend for AstraZeneca's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Other Current Liabilities Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

998,207.04

1,508,386.61

2,514,582.28

6,401,974.01

17,486,130.18

AstraZeneca Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															1,044,700.02	1,091,614.49	1,144,401.95	17,486,130.18	1,623,574.26

AstraZeneca Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

AstraZeneca Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (BUE:AZN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEG:Germany A1ZN34:Brazil AZNA:Austria

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.